Compensation cuts may be coming to in-house counsel across the U.S. as a result of the Covid-19 pandemic, but recent proxy filings show that 2019 was lucrative for some law department leaders.
The trademark feud embroiling the rock band Journey is in many ways a familiar story of bands struggling to untangle valuable rights when they split or disagree, spurred by big egos and even bigger piles of money. But its dispute is further complicated by an allegedly fraudulent corporate takeover and unusual structures around the band’s trademark on its name.
Drugmakers have pledged to provide millions or even billions of dollars’ worth of a medication for opioid-use disorder as part of opioid settlements reached with states and counties. However, some in the medical community say chemical dependence on the treatment could last years or even a lifetime for some patients. And that would let drugmakers profit from an addiction crisis they created.